Form 4 for ALT Altimmune, Inc.

Accepted 2024-02-01 00:00:00 ET · period of report 2024-01-30 · accession 0001104659-24-009538 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-01	2024-01-31	ALT	Eisenstadt Richard I	CFO	A - Grant	$2.69	+4,621	45.0K	+11%	+$12.4K
D	2024-02-01	2024-01-30	ALT	Eisenstadt Richard I	CFO	F - Tax	$9.80	-2,175	40.4K	-5%	-$21.3K
D	2024-02-01	2024-01-30	ALT	Eisenstadt Richard I	CFO	M - OptEx	$0.00	+9,275	42.6K	+28%	$0
D	2024-02-01	2024-01-30	ALT	Eisenstadt Richard I	CFO	M - OptEx	$0.00	-9,275	27.8K	-25%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.0001	2024-01-31	A	A	4,621	$2.69	45,012	D	—	—	(F4) In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2023.
2	Common	Common Stock, par value $0.0001	2024-01-30	F	D	2,175	$9.80	40,391	D	—	—
3	Common	Common Stock, par value $0.0001	2024-01-30	M	A	9,275	$0.00	42,566	D	—	—	(F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
4	Derivative	Restricted Stock Units	2024-01-30	M	D	9,275	$0.00	27,825	D	— · — to —	9,275 Common Stock, par value $0.0001	(F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.